$ADHC Long
Good play on a speculative migraine pain management device.
Around 600 M shares outstanding with low float and virtually no debt.
A small investment in
ADHC could yield exponential returns in a few short years.
Market cap could exceed to over 11B+ with successful FDA and clinical studies then successful marketplace execution.
Over $1 PPS is not unreasonable with this massive pain management market.
Good luck to longs.
Around 600 M shares outstanding with low float and virtually no debt.
A small investment in
ADHC could yield exponential returns in a few short years. Market cap could exceed to over 11B+ with successful FDA and clinical studies then successful marketplace execution.
Over $1 PPS is not unreasonable with this massive pain management market.
Good luck to longs.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.